Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-07-15
2008-07-15
Tucker, Zachary C (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S255050, C514S544000, C514S407000
Reexamination Certificate
active
07399766
ABSTRACT:
The present invention provides a pyrazinoylguanidine compound represented by formula (I):where the structural variables are as defined herein. The compounds are useful for promoting hydration of mucosal surfaces.
REFERENCES:
patent: 6858614 (2005-02-01), Johnson
patent: 6858615 (2005-02-01), Johnson
patent: 6903105 (2005-06-01), Johnson
patent: 2004/0198744 (2004-10-01), Johnson
patent: 2004/0198745 (2004-10-01), Johnson
patent: 2004/0198746 (2004-10-01), Johnson
patent: 2004/0198747 (2004-10-01), Johnson
patent: 2004/0198748 (2004-10-01), Johnson
patent: 2004/0198749 (2004-10-01), Johnson
patent: 2004/0204424 (2004-10-01), Johnson
patent: 2004/0204425 (2004-10-01), Johnson
patent: 2004/0229884 (2004-11-01), Johnson
patent: 2005/0059676 (2005-03-01), Johnson
patent: 2005/0080091 (2005-04-01), Johnson et al.
patent: 2005/0080093 (2005-04-01), Johnson et al.
patent: 2005/0090505 (2005-04-01), Johnson et al.
patent: 2005/0113388 (2005-05-01), Johnson
patent: 2005/0113389 (2005-05-01), Johnson
patent: 2005/0113390 (2005-05-01), Johnson
Collard et al, “Prevention of Ventilator-Associated Pneumonia: An Evidence-Based Systematic Review” Annals of Internal Medicine, vol. 138(6), pp. 494-501 (Mar. 18, 2003).
Thomas R. Kleyman, et al., “Distinct epitopes on amiloride. II. Variably restricted epitopes defined by monoclonal anti-amiloride antibodies”, American Journal of Physiology, vol. 260 (2, pt. 1), 1991, pp. C271-C276.
T. M. Cocks, et al., “Amiloride analogues cause endothelium-dependent relaxation in the canine coronary artery in vitro: possible role of Na+/Ca2+exchange”, British Journal of Pharmacology, vol. 95, 1988, pp. 67-76.
Oblon & Spivak, McClelland, Maier & Neustadt P.C.
Parion Sciences, Inc.
Tucker Zachary C
LandOfFree
Soluble amide & ester pyrazinoylguanidine sodium... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Soluble amide & ester pyrazinoylguanidine sodium..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Soluble amide & ester pyrazinoylguanidine sodium... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2759315